rs797045099
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001015880.2(PAPSS2):c.1662_1666delATTCC(p.Phe555SerfsTer15) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001015880.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAPSS2 | NM_001015880.2 | c.1662_1666delATTCC | p.Phe555SerfsTer15 | frameshift_variant | Exon 12 of 13 | ENST00000456849.2 | NP_001015880.1 | |
PAPSS2 | NM_004670.4 | c.1647_1651delATTCC | p.Phe550SerfsTer15 | frameshift_variant | Exon 11 of 12 | NP_004661.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAPSS2 | ENST00000456849.2 | c.1662_1666delATTCC | p.Phe555SerfsTer15 | frameshift_variant | Exon 12 of 13 | 1 | NM_001015880.2 | ENSP00000406157.1 | ||
PAPSS2 | ENST00000361175.8 | c.1647_1651delATTCC | p.Phe550SerfsTer15 | frameshift_variant | Exon 11 of 12 | 1 | ENSP00000354436.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Spondyloepimetaphyseal dysplasia, PAPSS2 type Pathogenic:1
The p.Phe555serfsX15 variant in PAPSS2 has not been previously reported in individuals with brachyolmia and was absent in large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 555 and leads to a premature termination codon 15 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Complete loss of PAPSS2 function has been identified in many individuals with brachyolmia (Faiyaz ul Haque 1998, Noordam 2009, Miyake 2012, Tuysuz 2013, Iida 2013), though all previously reported loss-of-function variants reside upstream of this variant. In summary, although additional studies are required to fully establish its clinical significance, the p.Phe555SerfsX15 variant is likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at